{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:52:50Z","timestamp":1781826770691,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.clon.2026.104173","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:00:58Z","timestamp":1776697258000},"page":"104173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The Role of Stereotactic Body Radiotherapy in Geriatric Patients With Oligometastatic Cancer: A Geriatric Oncology Perspective"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1941-4110","authenticated-orcid":false,"given":"T.","family":"Karg\u0131o\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9679-2572","authenticated-orcid":false,"given":"F.Y.","family":"Da\u015fg\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-9413","authenticated-orcid":false,"given":"A.K.","family":"Aksakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130pek P.","family":"Aral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1256-4412","authenticated-orcid":false,"given":"Z.","family":"\u015eahiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"\u0130nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Tezcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clon.2026.104173_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2026.104173_bib2","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.21037\/apm-20-1128","article-title":"Oligometastatic breast cancer: where are we now and where are we headed? A narrative review","volume":"10","author":"Kent","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"26","key":"10.1016\/j.clon.2026.104173_bib3","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1200\/JCO.2014.55.9567","article-title":"Radical irradiation of extracranial oligometastases","volume":"32","author":"Salama","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2026.104173_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1748-717X-6-80","article-title":"Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer","volume":"6","author":"Cheruvu","year":"2011","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.clon.2026.104173_bib5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5603\/RPOR.a2022.0017","article-title":"Stereotactic radiotherapy of oligometastatic disease: a new paradigm for a curative approach","volume":"27","author":"Krengli","year":"2022","journal-title":"Rep Pract Oncol Radiother"},{"issue":"24","key":"10.1016\/j.clon.2026.104173_bib6","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clon.2026.104173_bib7","first-page":"264","article-title":"Analysis of the elderly patient population in a tertiary-care university hospital","volume":"18","author":"Ju\u00e1rez","year":"2009","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"10185","key":"10.1016\/j.clon.2026.104173_bib8","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clon.2026.104173_bib9","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1470-2045(12)70510-7","article-title":"Stereotactic body radiotherapy for oligometastases","volume":"14","author":"Tree","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104173_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13014-025-02704-w","article-title":"Technical aspects of SBRT for therapy-refractory ventricular tachycardia: a systematic review for radiation oncologists","volume":"20","author":"Greiner","year":"2025","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104173_bib11","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1053","key":"10.1016\/j.clon.2026.104173_bib12","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150111","article-title":"The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly","volume":"88","author":"Scorsetti","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2026.104173_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40520-018-0937-6","article-title":"Oligometastatic cancer in elderly patients: the \u201cblitzkrieg\u201d radiotherapy approach","volume":"31","author":"Lancia","year":"2019","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.clon.2026.104173_bib14","doi-asserted-by":"crossref","first-page":"9247","DOI":"10.2147\/CMAR.S345871","article-title":"Efficacy and safety of local radiotherapy to all oligometastatic sites in elderly patients with metachronous oligometastatic cancers after initial treatment for the primary tumor","volume":"13","author":"Hu","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10.1016\/j.clon.2026.104173_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.semradonc.2021.11.009","article-title":"The role of ablative radiotherapy in older adults with limited metastatic disease","volume":"32","author":"Diplas","year":"2022","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104173_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/cancers15010244","article-title":"Stereotactic body radiotherapy and immunotherapy for older patients with oligometastases: a proposed paradigm by the International Geriatric Radiotherapy Group","volume":"15","author":"Nguyen","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.clon.2026.104173_bib17","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clon.2026.104173_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.eururo.2024.08.035","article-title":"Prostate cancer-related events in patients with synchronous metastatic hormone-sensitive prostate cancer treated with androgen deprivation therapy with and without concurrent radiation therapy to the prostate: data from the HORRAD trial","volume":"87","author":"Boev\u00e9","year":"2025","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clon.2026.104173_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003998","article-title":"Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: long-term results from the STAMPEDE randomised controlled trial","volume":"19","author":"Parker","year":"2022","journal-title":"PLoS Med"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526001445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526001445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:24:46Z","timestamp":1781825086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655526001445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":19,"alternative-id":["S0936655526001445"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2026.104173","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Stereotactic Body Radiotherapy in Geriatric Patients With Oligometastatic Cancer: A Geriatric Oncology Perspective","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2026.104173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104173"}}